Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management.
Saved in:
| Title: | Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management. |
|---|---|
| Authors: | Burns EA; Houston Methodist Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor, Houston, TX 77030, USA., Gentille C; Houston Methodist Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor, Houston, TX 77030, USA., Trachtenberg B; Houston Methodist DeBakey Heart and Vascular Center, 6565 Fannin St, Houston, TX 77030, USA., Pingali SR; Houston Methodist Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor, Houston, TX 77030, USA., Anand K; Callahan Cancer Center, Great Plains Health, 601 W Leota St, North Platte, NE 69101, USA. |
| Source: | Diseases (Basel, Switzerland) [Diseases] 2021 Mar 17; Vol. 9 (1). Date of Electronic Publication: 2021 Mar 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101636232 Publication Model: Electronic Cited Medium: Print ISSN: 2079-9721 (Print) Linking ISSN: 20799721 NLM ISO Abbreviation: Diseases Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2079-9721 |
|---|---|
| DOI: | 10.3390/diseases9010020 |
